Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02571738 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Phase 3 study, sponsored by Osiris Therapeutics.
- Terminated
- Registry status
- Phase 3
- Development phase
- 108
- Enrollment target
NCT02571738 is a Phase 3 study that was terminated before completion, run by Osiris Therapeutics. The registered enrollment target is 108 participants.
The verdict
NCT02571738, a Phase 3 study, was terminated before completion, sponsored by Osiris Therapeutics.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 108 participants
- Enrollment target
Study Summary
A Multicenter, Randomized, Single-Blind Study with an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Interventions
- OTHER Control
- BIOLOGICAL CHAM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02571738
The ClinicalTrials.gov registry entry for NCT02571738 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Osiris Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02571738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02571738 about?
NCT02571738 is a clinical study titled "Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers". A Multicenter, Randomized, Single-Blind Study with an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
What is the current status of trial NCT02571738?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 108 participants. The study started on 2015-10. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02571738?
The interventions under investigation include: Control (OTHER), CHAM (BIOLOGICAL).
Who is sponsoring clinical trial NCT02571738?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.